Clinical Trial AgreementTrial Agreement • June 14th, 2024 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledJune 14th, 2024 Company IndustryClinical Trial: Phase Ib Study With The Combination Of LB–100 (PP2A Inhibitor) And Atezolizumab (PD–L1 Inhibitor) In Metastatic Colorectal Cancer Patients – The CoLBAt Trial